Search

everythinglearnresearchcommunity

for

Search:↓

Adding cerium(III) chloride to Grignard reagents improves the making of compounds that could treat prostate issues and hair loss.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

The antibody 005-C04 blocks prolactin receptors, causing reversible infertility, impaired lactation, and hair regrowth in female mice.

Type 3 5α-reductase is more common and finasteride and dutasteride strongly inhibit it.

Combining L-cysteine, NAC, and a MET inhibitor significantly kills cervical cancer cells.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

A blood pressure drug, diltiazem, may also help treat influenza.

Nε-(carboxymethyl) lysine delays hair growth by blocking a key protein.

Cepharanthine and tetrandrine show promise as COVID-19 drugs.

Some dibenzo compounds might help treat cancer with fewer side effects.

Ritlecitinib can reduce inflammation and help hair regrow in Alopecia Areata.

New compounds show promise as nonsteroidal treatments for hair loss.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

Third-generation antihistamines are the safest and most effective for allergies.

Blocking certain brain processes reduces mating behavior in female rats.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

The new cocrystal KET-PABA is a more effective and safe anti-inflammatory treatment for skin conditions in mice.

Compounds from turmeric and bitter show strong potential as antiviral agents against the influenza A virus.

Small molecules KY19382 and KY19334 may help treat skin cancer by reducing CDK1 levels and blocking harmful cell signals.

TR3 is mainly found in hair follicle stem cells and may be involved in hair loss.

TRPV3 and TRPV6 channels change structure to regulate calcium and heat responses.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

Neuropeptides affect hair growth and could be used to control it.

MicroRNA-302 helps improve the conversion of body cells into stem cells by blocking NR2F2.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

EGCG may help regrow hair by inhibiting a specific enzyme.

Progesterone affects GABA_A receptor function by altering δ subunit levels.